In 2016, a neuroscientist at MIT published a finding that most people in mainstream medicine were not ready to take seriously: flickering light and sound at 40Hz — the frequency of gamma brainwaves — reduced amyloid plaques in the brains of mice. The same plaques that accumulate in Alzheimer’s disease. The same plaques the pharmaceutical industry has spent billions trying to eliminate with drugs.
Li-Huei Tsai’s lab at the Picower Institute for Learning and Memory did not use a drug. She used light and sound.
The paper ran in Nature. It was not a fringe publication. And since 2016, her lab has moved from mice to humans, with clinical trials now running at multiple institutions. Here is what the research has established, what it has not established, and what the evidence supports as a practical daily protocol.
What the MIT Research Found
The 2016 Nature paper documented that exposure to 40Hz flickering light — gamma frequency — drove microglia, the brain’s immune cells, to increase their activity and clear amyloid plaques more efficiently. The effect was specific to 40Hz. Other frequencies did not produce the same result.
Subsequent work from the Tsai lab extended the finding to auditory stimulation. 40Hz sound — a click or pulse at gamma frequency — produced the same microglial activation through the auditory pathway that visual stimulation produced through the visual system. Combining light and sound at 40Hz produced additive effects.
The proposed mechanism: gamma oscillations coordinate neural activity across brain regions in a way that optimizes the brain’s waste-clearance system. The glymphatic system — the brain’s lymphatic equivalent — operates most actively during slow-wave sleep and appears to be modulated by gamma activity. Driving gamma oscillations through external stimulation may support this clearance process.
What the Human Trials Are Showing
Clinical trials on gamma stimulation in humans are ongoing. Early human results have been cautiously encouraging. A 2021 pilot study at Georgia Tech found that 40Hz sensory stimulation was safe and well-tolerated in mild Alzheimer’s patients, with some participants showing stabilization in cognitive measures over the study period.
These are early-stage results. The research has not yet established that 40Hz stimulation prevents or reverses Alzheimer’s in humans. What it has established is that the mechanism is real, the intervention is safe, and the effect sizes in animal models are large enough to justify continued human investigation.
I track this research closely because it sits at the intersection of what I spent 20 years working on — clinical information systems that measure outcomes — and what they almost never captured: the daily sensory environment of the patient. No EHR records what a patient’s auditory environment looks like. No discharge summary asks about frequency exposure. This research suggests those omissions may matter more than we thought.
40Hz Audio: What to Actually Use
The Tsai lab used 40Hz clicks — single pulses at gamma frequency — in their auditory stimulation protocols. The sound is distinctive: a rapid clicking or buzzing at 40 times per second. At moderate listening volumes through headphones or speakers, it is tolerable for most people for 30–60 minute sessions.
For daily practice, a 40Hz gamma tone application provides a consistent, accurately calibrated source. The key parameter is frequency accuracy — the stimulation needs to be at 40Hz, not approximately 40Hz. Implementations vary in quality.
Disclosure: The author has a financial interest in 40Hz Gamma: Focus & Memory, a sound application that generates calibrated 40Hz gamma frequency audio. This disclosure is provided in compliance with FTC guidelines on endorsements and testimonials.
Protocol: How to Use 40Hz Gamma Audio
Based on the research protocols used in clinical studies:
- Duration: 30–60 minutes per session. Most clinical protocols used 1-hour sessions.
- Frequency: Daily. The animal studies used daily exposure; human protocols have followed the same cadence.
- Volume: Moderate — audible but not uncomfortable. You are not trying to overwhelm the auditory system; you are providing a consistent entrainment signal.
- Activity: The stimulation can be used during passive activity — reading, working at a computer, resting. It does not require focused attention on the sound itself.
- Combination: If using both audio and visual 40Hz stimulation (flickering light at gamma frequency), the research suggests additive benefit. Do not use visual stimulation if you have a history of photosensitive seizures.
What This Is Not
40Hz gamma stimulation is not a proven Alzheimer’s treatment. It is not approved by the FDA for any indication. It is an area of active clinical investigation with a credible mechanistic hypothesis and encouraging early results. That is different from established efficacy, and I will not overstate it.
What the research supports: regular exposure to 40Hz gamma frequency audio is safe, has a plausible mechanistic basis for supporting brain health, and is worth incorporating as a daily practice for anyone concerned about cognitive aging. It is not a substitute for the lifestyle factors with the strongest evidence base — sleep, exercise, and cardiovascular health — but it is a low-cost, low-risk addition to that foundation.
Content on this site is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health protocols.
Sources:
— Iaccarino, H.F. et al. (2016). Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature, 540, 230–235.
— Martorell, A.J. et al. (2019). Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell, 177(2), 256–271.
— He, et al. (2021). Gamma rhythm entrainment with 40 Hz sensory stimulation in mild Alzheimer’s disease — Georgia Tech pilot study.
